Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Show other versions (1)

Detalhes bibliográficos
Main Authors:	Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, McShane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U
Formato:	Journal article
Idioma:	English
Publicado em:	Public Library of Science 2008
Assuntos:	Medical sciences Vaccinology Infectious diseases

Registos relacionados

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
Por: Hanekom, W, et al.
Publicado em: (2008)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
Por: Willem A Hanekom, et al.
Publicado em: (2008-07-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
Por: Harris, S, et al.
Publicado em: (2013)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
Por: Ruggeberg, J, et al.
Publicado em: (2007)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
Por: Matsumiya, M, et al.
Publicado em: (2014)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
Por: Poyntz, HC
Publicado em: (2012)

Editorial: Reverse Vaccinology
Por: Richard Moxon, et al.
Publicado em: (2019-12-01)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
Por: Warrell, M, et al.
Publicado em: (2008)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
Por: Pollard, A, et al.
Publicado em: (2004)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
Por: Wang, LT
Publicado em: (2022)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
Por: Ronan, E
Publicado em: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
Por: Griffiths, K
Publicado em: (2012)

Innate immune responses to tuberculosis vaccines
Por: Matsumiya, M
Publicado em: (2014)

B cell responses to conjugate and polysaccharide meningococcal vaccines
Por: Ramasamy, M
Publicado em: (2012)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
Por: Bauza, K
Publicado em: (2012)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
Por: Alharbi, N
Publicado em: (2014)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
Por: Hennig, B, et al.
Publicado em: (2008)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
Por: Antrobus, R
Publicado em: (2014)

Data Behind Vaccine Hesitancy and Latest Updates on Vaccines in the Pipeline—2019 Annual Conference on Vaccinology Research, April 3–5, 2019
Por: William Schaffner, et al.
Publicado em: (2020-01-01)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
Por: Ochiai, R
Publicado em: (2011)

Antibody-based HIV-1 vaccines: recent developments and future directions
Por: Montefiori, D, et al.
Publicado em: (2007)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
Por: Elias, SC
Publicado em: (2014)

The Vaccinia Virus A36R Protein Is a Type Ib Membrane Protein Present on Intracellular but Not Extracellular Enveloped Virus Particles
Por: Van Eijl, H, et al.
Publicado em: (2000)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
Por: Kelly, C
Publicado em: (2013)

Epitope dominance studies with serotype O foot-and-mouth disease
Por: Borley, DW
Publicado em: (2012)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
Por: Olotu, A
Publicado em: (2013)

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
Por: Ahmed, T, et al.
Publicado em: (2014)

HIV-specific interleukin-10 responses and immune modulation
Por: Clutton, G
Publicado em: (2012)

Vaccines for the 21st century
Por: Isabel Delany, et al.
Publicado em: (2014-05-01)

The role of lung tissue-resident memory T cells in protection against tuberculosis
Por: Bull, N
Publicado em: (2017)

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
Por: Wan, L, et al.
Publicado em: (2012)

Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system
Por: Sadarangani, M
Publicado em: (2011)

Architecture of the HIV-1 glycan shield
Por: Pritchard, L
Publicado em: (2014)

T-cell receptor (TCR) usage in HIV-2 infection
Por: Moysi, E
Publicado em: (2012)

Enhancing the efficacy of viral vector blood-stage malaria vaccines
Por: Forbes, E
Publicado em: (2011)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
Por: Lee, Y, et al.
Publicado em: (2008)

Editorial: Precision vaccinology for infectious diseases
Por: Mahbuba Rahman, et al.
Publicado em: (2024-04-01)

Vaccine Evolution and Its Application to Fight Modern Threats
Por: Emanuele Andreano, et al.
Publicado em: (2019-07-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
Por: Pinpathomrat, N
Publicado em: (2018)

Global epidemiology of meningococcal disease and vaccine efficacy
Por: Pollard, A
Publicado em: (2004)